arrow
R

Roberta Fantozzi

Harvard T.H. Chan School of Public Health
H指数:22
被引数:1,604

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

High-fat diet promotes T cell–mediated synaptic dysfunction in multiple sclerosis

高脂饮食促进多发性硬化中T细胞介导的突触功能障碍

2026-09-230
OAAI
CSF Cytokine Network Organization Predicts Progression Independent of Relapse and MRI Activity in Multiple Sclerosis

脑脊液细胞因子网络组织预测多发性硬化症的进展,独立于复发和MRI活动

2026-09-030
OAAI
Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study)

评估接受不同治疗方案序列治疗的视神经脊髓炎患者队列中长期严重不良事件风险的概况:意大利视神经脊髓炎及相关疾病登记研究(I-MS&RD)(ProSA研究)结果

2026-07-040
PRE
The impact of multiple sclerosis on social determinants of health: Results from the SocialMS study

多发性硬化对社会决定性健康因素的影响:SocialMS研究的结果

2026-07-010
OAAI
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis

儿科起病多发性硬化中度疗效治疗后早期强化治疗的预测工具

2026-06-010
PRE
Cladribine in multiple sclerosis with autoimmune comorbidities: Further clinical insights from patients with rheumatologic disease treated in combination with secukinumab

氯达拉滨在伴有自身免疫性合并症的多发性硬化症中的应用:来自与司库奇尤单抗联合治疗的风湿性疾病患者的进一步临床见解

2026-04-260
PRE
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian study

真实世界中多发性硬化患者使用克拉屈滨片的经验:一项多中心意大利研究的有效性数据

2025-12-260
OA
IL-1β contributes to neurological disability in NMOSD AQP4 + Patients

IL-1β在NMOSD AQP4+患者中导致神经功能障碍。

2025-10-080
OA
Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty

真实世界中奥法鲁单抗治疗复发型多发性硬化24个月的效果:疗效、安全性及虚弱症的影响

2025-09-190
OAAI
Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study

多发性硬化患者S1P受体调节剂所致淋巴细胞减少症谱的实世界比较:一项多中心回顾性研究

2025-08-060
OAAI
Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective study

从 fingolimod 切换到 siponimod 的安全性评估:一项意大利多中心前瞻性研究

2025-07-010
PRE
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study

视神经脊髓炎谱系障碍中利妥昔单抗的长期有效性与安全性:一项5年观察性研究

2025-05-290
PRE
Effectiveness, safety, and impact on multiple sclerosis course of anti-CGRP monoclonal antibodies
2025-02-011
PRE
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy

怀孕期间暴露于富马酸二甲酯的多发性硬化症妇女的意大利多中心队列的母婴结局

2024-09-120
PRE
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis

Interleukin-10对比多发性硬化症中的炎性突触病和中枢神经退行性损伤

2024-08-070
OAAI
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis
2024-06-070
OAAI